Agreements are signed on Grippol Plus flu vaccine manufacturinglocalization in the Republic of Belarus and Iran.
Imoferaza®, an innovative special care cosmetic cream for post-trauma, post-surgical and post-acne scars is launched to the market.
The WHO approves bovhyaluronidase azoximer as the INN for Longidaze®.
The Russian Ministry of Health licenses Petrovax Pharm to manufacture Grippol® Plus, a Russian influenza vaccine, using flu antigens produced by St. Petersburg Research Institute for Vaccines and Sera of Russia’s Federal Medical and Biological Agency.
Partnership with Boehringer Ingelheim to localize a full-cycle manufacturing of the most advanced cardiovascular pharmaceutical products.
Polyoxidonium® wins the Russian Pharma Awards 2016 in the category The First Choice Immunomodulator for Acute Respiratory Infection in Sickly Children.
This site contains information for medical and pharmaceutical professionals. To view the content, please, confirm that you have the appropriate qualifications.